Florida biotech billionaire settles SEC stock manipulation case

By Jonathan Stempel

NEW YORK: Florida biotechnology billionaire Phillip Frost has agreed to pay $5.52 million to settle U.S. Securities and Exchange Commission civil charges over his alleged role in “pump-and-dump” schemes that left investors with virtually worthless stock.

The settlement requires Frost, the chairman and chief executive of Miami-based Opko Health Inc, to pay a $5 million fine and about $523,000 representing alleged ill-gotten gains and interest, according to a Thursday filing in Manhattan federal court.

Frost also accepted restrictions on trading penny stocks. Opko agreed to pay a $100,000 fine in a related settlement.

Neither defendant admitted or denied wrongdoing in agreeing to the settlements, which will end “potentially expensive, contentious and time-consuming litigation,” Frost said in a statement provided by Opko. Court approval is required.

A lawyer for Frost had no immediate additional comment.

Frost was among 10 people and 10 associated entities charged by the SEC on Sept. 7 with involvement from 2013 to 2018 in the manipulation of three companies’ share prices.

The SEC accused various defendants of buying large blocks of penny stocks at steep discounts, promoting the shares, and then quietly selling their stock at inflated prices, generating more than $27 million of improper gains.

Frost was allegedly involved in two of the schemes, the SEC said.

Now 82, Frost is worth $1.9 billion, Forbes magazine said on Thursday.

He had been chairman and chief executive of Ivax Corp before selling that drugmaker for $7.4 billion in 2006 to Israel-based Teva Pharmaceutical Industries Ltd, where he later served as chairman.

  • Related Posts

    Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

    Three teams inspected several wholesale medicine shops following complaints of sales without bills, storage irregularities and alleged illegal trading of government-supplied medicines. Patna: The Drug Department has launched an inspection…

    ‘Forthwith’ Under Drugs Act Does Not Mean Immediate Dispatch of Seized Drug Samples: Karnataka HC

    Bengaluru: The Karnataka High Court has refused to quash a prosecution against a pharmaceutical firm and its managing partner under Sections 18(a)(i) and 27(d) of the Drugs and Cosmetics Act,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

    Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

    ‘Forthwith’ Under Drugs Act Does Not Mean Immediate Dispatch of Seized Drug Samples: Karnataka HC

    ‘Forthwith’ Under Drugs Act Does Not Mean Immediate Dispatch of Seized Drug Samples: Karnataka HC

    A Worthy New Leader takes the Torch @Sir Ganga Ram Hospital

    A Worthy New Leader takes the Torch @Sir Ganga Ram Hospital

    CBI arrests two NCB staffers for demanding Rs 25 lakh bribe from a chemist in UP

    CBI arrests two NCB staffers for demanding Rs 25 lakh bribe from a chemist in UP

    Delhi Police bust fake Unani healthcare call centre in Pitampura; 12 arrested

    Delhi Police bust fake Unani healthcare call centre in Pitampura; 12 arrested

    Sakeena Itoo reviews functioning of Drug Testing Laboratory, GMC Kathua

    Sakeena Itoo reviews functioning of Drug Testing Laboratory, GMC Kathua